Renalytix company information, Employees & Contact Information

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease PR Newswire

MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities Yahoo Finance

15M Diabetic Kidney Patients: Renalytix and Tempus Launch Groundbreaking AI Testing Partnership Stock Titan

Confirmation of receipt of £860k R&D tax credits Sharecast.com

REG - Renalytix PLC - Additional Subscription for 11m Shares TradingView

Renalytix shares surge 45% on Tempus collaboration Proactive Investors

Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 PR Newswire

AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics The Armchair Trader

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease Mount Sinai

Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference GlobeNewswire

Diagnostics Biz Renalytix Raises £7M For Testing Program Law360

Renalytix Secures Additional Institutional Investment to Bolster U.S. Market Expansion TipRanks

Renalytix Appoints Timothy Scannell to Board citybiz

Renalytix scores long-awaited FDA de novo nod for AI-powered kidney disease test Fierce Biotech

Renalytix faces delisting from Nasdaq over noncompliance Investing.com

Renalytix Partners with Tempus AI to Broaden Access to Kidney Disease Testing TipRanks

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model Yahoo Finance

Renalytix Plc Announces £500,000 Retail Offer to Bolster Financial Position TipRanks

Renalytix Announces Fundraise to Support US Expansion TipRanks

Renalytix Updates Revenue Guidance Amid New Tempus Collaboration TipRanks

UBS Group AG Acquires Significant Stake in Renalytix PLC TipRanks

Renalytix AI adds new biomarkers to platform for tricky to diagnose CKD Mobi Health News

KidneyIntelX™ Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care Stock Titan

JPM 2022: Renalytix plots de novo FDA nod for kidney disease AI, expands into drug response monitoring Fierce Biotech

Renalytix plc Announces Collaboration with Tempus AI, Inc. to Advance Intelligent Risk Assessment in Diabetic Kidney Disease MarketScreener

Renalytix shares slump as revenue guidance revised after Tempus deal MarketScreener

Renalytix AI and Kidney Disease Diagnostics Nanalyze

Renalytix upsized fundraise brings in £7m Proactive Investors

Renalytix AI raises $29M through IPO for AI-based kidney disease diagnostics MedCity News

Potential takeover at Renalytix plc falls through BusinessCloud

AIM Market Roundup: Future Metals, Renalytix, Nativo Resources The Armchair Trader

Is Renalytix the best penny stock to buy today? Fool UK

Renalytix plc welcomes returning chair with executive remit BusinessCloud

After the Renalytix share price jumps 500% in 3 days, is it time to buy? Fool UK

Three Quick Facts: London Stock Exchange, Serco, Renalytix The Armchair Trader